Table 1.
Demographic and Medical Characteristics of Participants
Characteristic | All Patients |
UC Group |
AT Group |
P | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | % | Mean | SD | No. | % | Mean | SD | No. | % | Mean | SD | ||
No. of patients | 90 | 100 | 43 | 48 | 47 | 52 | |||||||
Age, years | 66 | 11 | 66 | 11 | 66 | 10 | .861 | ||||||
Female sex | 23 | 26 | 10 | 23 | 13 | 28 | .632 | ||||||
Weight, kg | 85.1 | 19.8 | 86.6 | 21.7 | 83.8 | 18.2 | .507 | ||||||
BMI, kg/m2 | 28 | 6 | 29 | 8 | 28 | 5 | .385 | ||||||
Heart rate, beats · min–1 | 71 | 11 | 72 | 11 | 70 | 11 | .269 | ||||||
Systolic blood pressure, mmHg | 116 | 19 | 117 | 20 | 115 | 18 | .634 | ||||||
Diastolic blood pressure, mmHg | 70 | 10 | 69 | 9 | 70 | 11 | .422 | ||||||
NYHA class | .344 | ||||||||||||
II | 57 | 63 | 29 | 67 | 28 | 60 | |||||||
III | 31 | 34 | 14 | 33 | 17 | 36 | |||||||
IV | 2 | 2 | 0 | 0 | 2 | 4 | |||||||
Race/ethnicity | .810 | ||||||||||||
White | 59 | 66 | 28 | 65 | 31 | 67 | |||||||
African American | 27 | 30 | 14 | 33 | 13 | 28 | |||||||
Other | 3 | 3 | 1 | 2 | 2 | 4 | |||||||
Left ventricular ejection fraction, % | 26 | 8 | 27 | 8 | 24 | 8 | .188 | ||||||
Comorbid conditions | |||||||||||||
Diabetes | 34 | 38 | 19 | 44 | 15 | 32 | .230 | ||||||
Previous MI | 44 | 49 | 18 | 42 | 26 | 55 | .202 | ||||||
Hypertension | 52 | 58 | 28 | 65 | 24 | 51 | .177 | ||||||
Atrial fibrillation or atrial flutter | 18 | 20 | 7 | 16 | 11 | 23 | .398 | ||||||
Sodium | 139.5 | 2.7 | 139.5 | 2.9 | 139.4 | 2.4 | .941 | ||||||
Serum creatinine | 1.5 | 1.3 | 1.4 | 0.5 | 1.6 | 1.8 | .353 | ||||||
Medications and devices | |||||||||||||
ACE inhibitor or ARB | 85 | 94 | 40 | 93 | 45 | 96 | .573 | ||||||
Beta blocker | 79 | 88 | 41 | 95 | 38 | 81 | .036 | ||||||
Aldosterone | 34 | 38 | 13 | 30 | 21 | 45 | .157 | ||||||
Loop diuretic | 65 | 72 | 33 | 77 | 32 | 68 | .359 | ||||||
Digoxin | 44 | 49 | 19 | 44 | 25 | 53 | .393 | ||||||
Implantable cardioverter-defibrillator | 35 | 39 | 15 | 35 | 20 | 43 | .456 | ||||||
Biventricular pacemaker | 16 | 18 | 8 | 19 | 8 | 17 | .844 |
NOTE. Continuous variables are reported as mean and standard deviation (SD); categorical variables are reported as No. and %.
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; AT, aerobic training; BMI, body mass index; MI, myocardial infarction; NYHA, New York Heart Association; UC, usual care.